Company / Current Assets
ClearPoint Neuro, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$63.6M
FY2025
5-year range
$33.4M / $63.6M
FY2021-FY2025
Trend
+90.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets returned to growth in FY2025 after 3 years of decline, reaching $64M.
Based on SEC 10-K filings.
$64M in FY2025 with a 5-year CAGR of +20.1%.
Improved from $36M to $64M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +7.5%
- 5-Year CAGR
- +20.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +20.1%, indicating consistent growth.
- In FY2025, current assets increased 90.6% year-over-year.
- Lowest current assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.71 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $63.6M | +90.6% |
| FY2024 | $33.4M | -7.8% |
| FY2023 | $36.2M | -29.3% |
| FY2022 | $51.2M | -17.3% |
| FY2021 | $61.9M | +143.1% |
| FY2020 | $25.5M | +145.2% |
| FY2019 | $10.4M | +56.0% |
| FY2018 | $6.7M | -47.8% |
| FY2017 | $12.7M | +109.5% |
| FY2016 | $6.1M | -28.7% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026